Everyone remembers a good teacher. However, a flight instructor for the commercial aviation industry is mentoring students who will go on to be responsible for thousands of people’s lives over the course of their career. Artemis Aerospace looks at the work of the people who teach pilots…
Month: March 2024
Everyone remembers a good teacher. However, a flight instructor for the commercial aviation industry is mentoring students who will go on to be responsible for thousands of people’s lives over the course of their career. Artemis Aerospace looks at the work of the people who teach pilots…
PARIS, 18. März 2024 /PRNewswire/ — Chinas führende Social-Media- und Lifestyle-Plattform XIAOHONGSHU x VOGUE Business veranstaltet während der Pariser Modewoche 2024 am 4. und 5. März den China Digital Excellence Summit und das Gala Dinner. Die Veranstaltung, ein Treffpunkt für…
PARIS, 18. März 2024 /PRNewswire/ — Chinas führende Social-Media- und Lifestyle-Plattform XIAOHONGSHU x VOGUE Business veranstaltet während der Pariser Modewoche 2024 am 4. und 5. März den China Digital Excellence Summit und das Gala Dinner. Die Veranstaltung, ein Treffpunkt für…
NEW YORK, March 18, 2024 /PRNewswire/ — The global extended reality market size is estimated to grow by USD 443.26 bn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of almost 43.09% during the forecast period. The Extended Reality (XR) market,…
NEW YORK, March 18, 2024 /PRNewswire/ — The global extended reality market size is estimated to grow by USD 443.26 bn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of almost 43.09% during the forecast period. The Extended Reality (XR) market,…
OSLO, Norway, March 18, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today the Phase III clinical study results for its non-surgical treatment candidate for cervical high-grade…
OSLO, Norway, March 18, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today the Phase III clinical study results for its non-surgical treatment candidate for cervical high-grade…
OSLO, Norway, March 18, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today the Phase III clinical study results for its non-surgical treatment candidate for cervical high-grade…
OSLO, Norway, March 18, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today the Phase III clinical study results for its non-surgical treatment candidate for cervical high-grade…